Related Experiment Videos
CD28/CTLA-4 and CD80/CD86 families: signaling and function.
J M Slavik1, J E Hutchcroft, B E Bierer
1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Immunologic Research
|June 22, 1999
Summary
T cell activation requires costimulatory signals to prevent anergy and cell death. The CD28 receptor family, including CD28 and CTLA-4, interacts with B7 ligands (CD80/CD86) to regulate T cell responses.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- T cell activation is critically dependent on costimulatory signals beyond initial antigen recognition.
- Absence of costimulation can result in T cell anergy or apoptosis.
- CD28 is a key costimulatory receptor essential for preventing these negative outcomes.
Purpose of the Study:
- To review the CD28 and CTLA-4 receptor families and their B7 ligands (CD80/CD86).
- To outline the functional consequences of CD28 ligation.
- To describe the biochemical signaling pathways activated by CD28 engagement.
Main Methods:
- Literature review of CD28/CTLA-4 and CD80/CD86 families.
- Analysis of functional outcomes of T cell costimulation.
- Examination of intracellular signaling cascades downstream of CD28.
Main Results:
- CD28 and CTLA-4 represent a major receptor family involved in T cell regulation.
- CD80 and CD86 are the primary ligands for CD28 and CTLA-4.
- CD28 engagement promotes T cell activation, proliferation, and survival, while CTLA-4 typically inhibits these processes.
Conclusions:
- The CD28/CTLA-4 and CD80/CD86 interactions are fundamental to controlling T cell immune responses.
- Understanding these pathways is crucial for developing immunotherapies.
- Differential signaling downstream of CD28 and CTLA-4 dictates distinct cellular outcomes.